ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Metagenomi Inc

Metagenomi Inc (MGX)

2.48
-0.16
(-6.06%)
Closed February 08 4:00PM
2.5599
0.0799
(3.22%)
After Hours: 7:38PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
2.5599
Bid
2.50
Ask
2.56
Volume
640,704
2.46 Day's Range 2.67
1.61 52 Week Range 12.74
Market Cap
Previous Close
2.64
Open
2.61
Last Trade
10
@
2.5585
Last Trade Time
Financial Volume
$ 1,633,709
VWAP
2.5499
Average Volume (3m)
2,556,464
Shares Outstanding
37,423,917
Dividend Yield
-
PE Ratio
-1.36
Earnings Per Share (EPS)
-1.82
Revenue
44.76M
Net Profit
-68.26M

About Metagenomi Inc

At Metageno-mi, we are cre-at-ing poten-tial-ly cura-tive ther-a-peu-tics using our metage--nomics-pow-ered genome edit-ing toolbox.We believe tools with capa-bil-i-ties that go beyond the cur-rent tech-nol-o-gy land-scape will be required in order to reach the full ther-a-peu-tic poten-tial of geno... At Metageno-mi, we are cre-at-ing poten-tial-ly cura-tive ther-a-peu-tics using our metage--nomics-pow-ered genome edit-ing toolbox.We believe tools with capa-bil-i-ties that go beyond the cur-rent tech-nol-o-gy land-scape will be required in order to reach the full ther-a-peu-tic poten-tial of genome edit-ing. By har-ness-ing the pow-er of metage-nomics, the study of genomes recov-ered from uncul-ti-vat-ed organ-isms in the nat-ur-al envi-ron-ment, we are dis-cov-er-ing and devel-op-ing a suite of nov-el genome edit-ing tools with the poten-tial to make any desired ther-a-peu-tic gene edit, any-where in the human genome. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Wilmington, Delaware, USA
Founded
-
Metagenomi Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker MGX. The last closing price for Metagenomi was $2.64. Over the last year, Metagenomi shares have traded in a share price range of $ 1.61 to $ 12.74.

Metagenomi currently has 37,423,917 shares outstanding. The market capitalization of Metagenomi is $98.80 million. Metagenomi has a price to earnings ratio (PE ratio) of -1.36.

MGX Latest News

Metagenomi Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated Milestones

MGX-001 in Hemophilia A Advances Towards US and Ex-US Regulatory Interactions in 2025 NHP Proof-of-Concept Anticipated for Secreted Protein Deficiency Platform in 2025 Leveraging MGX-001 Editing...

Metagenomi Announces New Appointment to its Board of Directors

EMERYVILLE, Calif., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its...

Metagenomi to Present at the 43rd Annual J.P. Morgan Healthcare Conference

EMERYVILLE, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its...

Metagenomi Presents Highly Specific and Efficient Genome Editing Tools at Nature Conference β€œRNA at the Bench and Bedside IV”

MGX-001, utilizing a highly specific and efficient MG29-1 nuclease, exhibits no identifiable off-target editing MG29-1 nuclease targeting the albumin safe harbor locus showed no evidence of...

Metagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th Annual Meeting

Therapeutically relevant levels of Factor VIII (FVIII) activity sustained in ongoing nonhuman primate (NHP) study through more than sixteen months of follow up MGX-001 bioengineered FVIII...

The Gross Law Firm Notifies Metagenomi, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MGX

The Gross Law Firm Notifies Metagenomi, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MGX PR Newswire NEW YORK, Nov. 22, 2024 NEW YORK, Nov. 22, 2024 /PRNewswire/ -- The Gross...

November 25, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against MGX

November 25, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against MGX PR Newswire NEW YORK, Nov. 21, 2024 NEW YORK, Nov. 21, 2024 /PRNewswire/ -- The Gross Law Firm issues...

Investors who lost money on Metagenomi, Inc.(MGX) should contact The Gross Law Firm about pending Class Action - MGX

Investors who lost money on Metagenomi, Inc.(MGX) should contact The Gross Law Firm about pending Class Action - MGX PR Newswire NEW YORK, Nov. 18, 2024 NEW YORK, Nov. 18, 2024 /PRNewswire/...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.2901-10.17894736842.852.952.43315980832.62033926CS
4-0.5501-17.68810289393.1142.433117128982.88723105CS
120.7049381.8554.921.6125564643.65787393CS
26-1.2001-31.91755319153.764.921.6112497623.49336542CS
52-7.6901-75.025365853710.2512.741.616970253.99102813CS
156-7.6901-75.025365853710.2512.741.616970253.99102813CS
260-7.6901-75.025365853710.2512.741.616970253.99102813CS

MGX - Frequently Asked Questions (FAQ)

What is the current Metagenomi share price?
The current share price of Metagenomi is $ 2.5599
How many Metagenomi shares are in issue?
Metagenomi has 37,423,917 shares in issue
What is the market cap of Metagenomi?
The market capitalisation of Metagenomi is USD 98.8M
What is the 1 year trading range for Metagenomi share price?
Metagenomi has traded in the range of $ 1.61 to $ 12.74 during the past year
What is the PE ratio of Metagenomi?
The price to earnings ratio of Metagenomi is -1.36
What is the cash to sales ratio of Metagenomi?
The cash to sales ratio of Metagenomi is 2.07
What is the reporting currency for Metagenomi?
Metagenomi reports financial results in USD
What is the latest annual turnover for Metagenomi?
The latest annual turnover of Metagenomi is USD 44.76M
What is the latest annual profit for Metagenomi?
The latest annual profit of Metagenomi is USD -68.26M
What is the registered address of Metagenomi?
The registered address for Metagenomi is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Metagenomi website address?
The website address for Metagenomi is www.metagenomi.co
Which industry sector does Metagenomi operate in?
Metagenomi operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MGOLMGO Global Inc
$ 0.4191
(126.54%)
780.46M
CDTConduit Pharmaceuticals Inc
$ 2.831
(82.65%)
140.32M
GSIWGarden Stage Ltd
$ 0.79
(78.73%)
215.16M
TOIIWOncology Institute Inc
$ 0.033
(58.88%)
7.27k
CYTHCyclo Therapeutics Inc
$ 1.19
(54.55%)
72.39M
FTELFitell Corporation
$ 2.70
(-57.01%)
2.28M
SGBXSafe and Green Holdings Corporation
$ 0.6401
(-44.82%)
5.15M
NKLANikola Corporation
$ 0.4432
(-41.10%)
47.43M
PLRXPliant Therapeutics Inc
$ 7.785
(-34.85%)
6.4M
LIPOLipella Pharmaceuticals Inc
$ 3.08
(-33.76%)
2.08M
MGOLMGO Global Inc
$ 0.4191
(126.54%)
816.59M
RIMEAlgorhythm Holdings Inc
$ 0.0169
(-20.66%)
274.2M
NVDANVIDIA Corporation
$ 129.84
(0.90%)
228.2M
GSIWGarden Stage Ltd
$ 0.79
(78.73%)
219.64M
BHATBlue Hat Interactive Entertainment Technology
$ 0.0537
(14.74%)
212.29M

MGX Discussion

View Posts
tw0122 tw0122 2 weeks ago
MGX $3.28 + 20% Gene editing AI play juice it $3.77-$4,03 in cards 
👍 1
theorysuit theorysuit 3 weeks ago
LFG, she got her 2nd Wind!
👍 1
theorysuit theorysuit 1 month ago
1.81 to 4.92 with a normal retrace of 2.92. This stock still trades at under cash value. I have near to mid term fib targets of 6, 6.49, 6.87, 7.21, 7.58, 7.95, and 8.47 if you are looking for some exit points.
πŸ‘οΈ0
Landwehr Landwehr 1 month ago
I enjoy the violatility of this stock. However, a news release will get us past 5.00 and into 6s
πŸ‘οΈ0
KIPK KIPK 1 month ago
A true theorySLUT paid to post theorySHIT on multiple massage boards..

KARMA in not a theory, Its a selftrap for good...
πŸ‘οΈ0
Landwehr Landwehr 2 months ago
There hasn't been any news in a while. However, the chart is looking really good
πŸ‘οΈ0
Monksdream Monksdream 2 months ago
MGX under $5

[color=red][/color]
👍 1
Landwehr Landwehr 2 months ago
MGX still looking good. A mild new release will send this to 4.5. 
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 2 months ago
GAVE IT A CHANCE...SOLD IT
πŸ‘οΈ0
Landwehr Landwehr 2 months ago
We need a news release for this to go back up. I'm long on this stock 
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 2 months ago
MGX GAPPING BACK UP...LAST ATTEMPT
πŸ‘οΈ0
Landwehr Landwehr 2 months ago
If we can continue to consolidate and churn in this range for a few days we will be in good shape for the next news cycle. 
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 2 months ago
5 DAY DOWN TREND SEEMS TO HAVE STOPPED
πŸ‘οΈ0
Landwehr Landwehr 2 months ago
Very good consolidation while no new news
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 2 months ago
MGX BUILDING A FOUNDATION
👍 1
Landwehr Landwehr 2 months ago
The next news release will ignite this stock. 
πŸ‘οΈ0
dinogreeves dinogreeves 2 months ago
No, they are well funded well into 2025 and even beyond late 2025.
πŸ‘οΈ0
Millenium323 Millenium323 2 months ago
Bayer Healthcare bought a 10.8% stake in $MGX according to a Nov 6th filing. Bayer is a multibillion dollar company who is known for their Hemophilia Division. This happens to correspond to MGX's strength which is their Hemophilia pipeline

https://www.otcmarkets.com/filing/html?id=17946805&guid=3xY-kK_WErmSJth
👍 1
Landwehr Landwehr 2 months ago
This is going to be a fun ride. Alot of volatility. It will get back close to 10 in the next couple months. Even if it's speculation 
πŸ‘οΈ0
dinogreeves dinogreeves 2 months ago
I sold at $4.50.
πŸ‘οΈ0
frans frans 2 months ago
MGX need money ???
πŸ‘οΈ0
frans frans 2 months ago
MGX company work for MM not for shaholders and selling shares into market
πŸ‘οΈ0
frans frans 2 months ago
all schort what I see on my L2 MM's 10 - 12 sametime
πŸ‘οΈ0
theorysuit theorysuit 2 months ago
This is how these bios move. You get the early stage upwave which we are in. They will bring it down closer to commercialization again. Ride this upwave and expect periods of pullbacks and consolidation.
πŸ‘οΈ0
Landwehr Landwehr 2 months ago
I wouldn't consider this stock a pump and dump. I do agree on the way to the 52 week low that shook alot of weak hands. Now with three sources of revenue and some of their products entering a new phase before production, this stock is getting noticed 
πŸ‘οΈ0
frans frans 2 months ago
I am not out I am long
πŸ‘οΈ0
theorysuit theorysuit 2 months ago
Stage 1 pump. They shook everyone out on the drive to 1.60. This is how stocks move.
πŸ‘οΈ0
Landwehr Landwehr 2 months ago
A ride to $10
πŸ‘οΈ0
frans frans 2 months ago
what is going on here ??
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 2 months ago
MGX MONSTER
πŸ‘οΈ0
dinogreeves dinogreeves 2 months ago
This is why it ran today with no news, someone knew it was coming

https://finance.yahoo.com/news/metagenomi-presents-updated-preclinical-data-021600360.html
πŸ‘οΈ0
dinogreeves dinogreeves 2 months ago
Corporate presentation just an hour ago.

https://dbzipdrh8te83.cloudfront.net/MGX-ASH-December-2024.pdf
πŸ‘οΈ0
dinogreeves dinogreeves 2 months ago
Great update! Hemophilia drug market was estimated to be 12.1 billion this year. 18.7 billion by 2034. I wonder how much they’ll charge for a cure….. or governments will pay for it. Amazing opportunity here. Stoked for the years ahead.
πŸ‘οΈ0
dinogreeves dinogreeves 2 months ago
https://metagenomi.co/discovery-platform
πŸ‘οΈ0
dinogreeves dinogreeves 2 months ago
This has 8-10 dollars written all over it in a week. Gene therapy is huge market, very huge.
πŸ‘οΈ0
dinogreeves dinogreeves 2 months ago
Yup, this is real good one, I am still holding. Bought, then went out of the house to run errands. Over 7 dollars book value and revenues.
👍 1
Monksdream Monksdream 2 months ago
Metagenomi, Inc. is a precision genetic medicines company, which engages in the business of developing next generation gene-editing technologies and therapies. Its business activities include developing gene editΒ­ing toolbox, therΒ­aΒ­peuΒ­tic focus, and processing discovery platform. The company was founded by Brian C. Thomas on September 16, 2016 and is headquartered in Emeryville, CA. The listed name for MGX is Metagenomi, Inc. Common Stock
πŸ‘οΈ0
Monksdream Monksdream 2 months ago
UP OFF THE MAT, maybe it will grow legs
πŸ‘οΈ0
Landwehr Landwehr 2 months ago
This could get to $5 this week
πŸ‘οΈ0
glenn1919 glenn1919 2 months ago
MGX..................https://stockcharts.com/h-sc/ui?s=MGX&p=W&b=5&g=0&id=p86431144783
👍 1
eur06 eur06 2 months ago
Just got on line….it looks pretty good!!
Trying to get some.
πŸ‘οΈ0
theorysuit theorysuit 2 months ago
LfG!
πŸ‘οΈ0
dinogreeves dinogreeves 2 months ago
Will run to 10 dollars within a week. Insiders and Tutes bought above 10 dollars.
👍 1
TrendTrade2016 TrendTrade2016 2 months ago
mgx blowing up
πŸ‘οΈ0
dinogreeves dinogreeves 2 months ago
1000% gains coming here, jumped in at 2.28 this morning with 4000 shares.
👍 1
KIPK KIPK 5 months ago
POS ....You are
πŸ‘οΈ0
KIPK KIPK 5 months ago
You are a POS dude....
πŸ‘οΈ0
theorysuit theorysuit 5 months ago
Added again here in full size. Data looks fantastic.
πŸ‘οΈ0
theorysuit theorysuit 5 months ago
https://finance.yahoo.com/news/metagenomi-announces-preclinical-data-lead-200500503.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr

Efficacy and Durability looks promising here. Lotto sized play here sub $3. I think Stage 1 Pump incoming. A deal to replace MRNA would be nice.
πŸ‘οΈ0
theorysuit theorysuit 6 months ago
buying in small chunks under $3.
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock